The inflammatory response in interleukin-1β-deficient mice: Comparison with other cytokine-related knock-out mice

Journal of Leukocyte Biology

Volumn 59, Issue 4, 1996, Pages 489-493

  Fantuzzi, Giamila ^a,b   Dinarello, Charles A ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase response; Interferon ; Interleukin 6; Lipopolysaccharide; Tumor necrosis factor ; Turpentine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TURPENTINE;

ACUTE PHASE RESPONSE; IMMUNE DEFICIENCY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030013088     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.59.4.489     Document Type: Review

References (41)

1. Dinarello, C.A. (1994) The biological properties of IL-1. Eur. Cytokine. Netw. 5, 517-531.
2. Dripps, D.J., Brandhuber, B.J., Thompson, R.C., Eisenberg, S.P. (1991) Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa receptor but does not initiate IL-1 signal transduction J. Biol. Chem. 266, 10331-10336.
3. Alexander, H.R., Doherty, G.M., Buresh, C.M., Venzon, D.J., Norton, J.A. (1991) A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173, 1029-1032.
4. Ohlsson, K., Bjork, P., Bergenfeldt, M., Hageman, R., Thompson, R.C. (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxic shock. Nature 348, 550-552.
5. Wakabayashi, G., Gelfand, J.A., Burke, J.F., Thompson, R.C., Dinarello, C.A. (1991) A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5, 338-343.
6. Gershenwald, J.E., Fong, Y., Fahey, T.J.I., Calvano, S.E., Chizzonite, R., Kilian, P.L., Lowry, S.F., Moldawer, L.L. (1990) Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 87, 4966-4970.
7. Vidal-Vanaclocha, F., Mezaga, C., Asumendi, A., Kaplanski, G., Dinarello, C.A. (1994) Interleukin-1 receptor blockade reduces the number and size of murine B 16 melanoma hepatic metastasis. Cancer Res. 54, 2667-2672.
8. Nicoletti, F., Di Marco, R., Barcellini, W., Magro, G., Schorlemmer, H.U., Kurrle, R., Lunetta, M., Grasso, S., Zaccone, P., Meroni, P.L. (1994) Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur. J. Immunol. 24, 1843-1847.
9. Sandberg, J.-O., Eizirik, D.L., Sandler, S., Tracey, D.R., Andersson, A. (1993) Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival. Diabetes 42, 1845-1851.
10. Jacobs, C.A., Baker, P.E., Roux, E.R., Picha, K.S., Toivola, B., Waugh, S., Kennedy, M.K. (1991) Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 146, 2983-2989.
11. Karkar, A.M., Koshino, Y., Cashman, S.J., Dash, A.C., Bonnefoy, J., Meager, A., Rees, A.J. (1992) Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing injury in nephrotoxic nephritis in rats. Clin. Exp. Immunol. 90, 312-318.
12. Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K., Conn, C.A., Soszynski, D., Grabiec, C., Trumbauer, M.E., Shaw, A., Kostura, M.J., Stevens, K., Rosen, H., North, R.J., Chen, H.Y., Tocci, M.J., Kluger, M.J., Van der Ploeg, L.H.T. (1995) Resistance to lever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity 3, 9-19.
13. Fattori, E., Cappelletli, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., Poli, V. (1994) Defective inflammatory response in interleukin-6 deficient mice. J. Exp. Med. 180, 1243-1250.
14. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., Kohler, G. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.
15. Fantuzzi, G., Faggioni, R., Sironi, M., Ghezzi, P., Sipe, J.D., Zheng, H., van der Ploeg, L.H.T., Shaw, A.R., Dinarello, C.A. (1995) Reduced inflammatory response and cytokine synthesis in interleukin-1β -deficient mice. Cytokine 7, 608 (Abstract).
16. Bank, U., Schneemilch, C., Reinliold, D., Kunz, D., Ansorge, S. (1995) Kinetics of cytokine secretion in locally restricted inflammatory processes following tissue injury in vivo. Cytokine 7, 618 (Abstract).
17. Fantuzzi, G., Ghezzi, P. (1993) Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases. Mediat. Inflamm. 2, 263-270.
18. Dinarello, C.A. (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652.
19. Ikejima, T., Okusawa, S., Ghezzi, P., van der Meer, J.W.M., Dinarello, C.A. (1990) Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and circulating TNF-like activity in rabbits. J. Infect. Dis. 162, 215-223.
20. Dinarello, C.A., Cannon, J.G., Wolff, S.M., Bernheim, H.A., Beutler, B., Cerami, A., Figari, I.S., Palladino, M.A., O'Connor, J.V. (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163, 1433-1450.
21. Waage, A., Espevik, T. (1988) Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J. Exp. Med. 167, 1987-1992.
22. Granowitz, E.V., Porat, R., Mier, J.W., Orencole, S.F., Callahan, M.V., Cannon, J.G., Lynch, E.A., Ye, K., Poutsiaka, D.D., Vannier, E., Shapiro, L., Pribble, J.P., Stiles, D.M., Catalano, M.A., Wolff, S.M., Dinarello, C.A. (1993) Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood 82, 2985-2990.
23. Van Zee, K.J., Coyle, S.M., Calvano, S.E., Oldenburg, H.S.A., Stiles, D.M., Pribble, J., Catalano, M.A., Moldawer, L.L., Lowry, S.F. (1995) Influence of IL-1 receptor blockade on the human response to endotoxemia. J. Immunol. 154, 1499-1507.
24. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Jonhston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tracey, D., Warwell, S., Wei, F.-Y., Wong, W., Kamen, R., Seshadri, T. (1995) Mice deficient in IL-1β -converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80, 401-411.
25. Aderka, D., Le, J., Vilcek, J. (1989) IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and mice. J. Immunol. 143, 3517-3523.
26. Kohase, M., Henriksen-De Stefano, D., May, L.T., Vilcek, J., Sehgal, P.B. (1986) Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45, 659-666.
27. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., Bluethmann, H. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria, monocytogenes. Nature 364, 798-802.
28. d (endotoxin resistance) phenotype. J. Exp. Med. 164, 1791-1796.
29. Car, B.D., Eng, V.M., Schnyder, B., Ozmen, L., Huang, S., Gallay, P., Heumann, D., Aguet, M., Ryffel, B. (1994) Interferon-γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179, 1437-1444.
30. Kamijo, R., Le, J., Shapiro, D., Havell, E.A., Huang, S., Aguet, M., Bosland, M., Vilcek, J. (1993) Mice that lack the interferon-γ receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178, 1435-1440.
31. Pfeffer, K., Matsuyama, T., Kundig, T.M., Wakenian, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P.S., Kronke, M., Mak, T.W. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467.
32. Garcia, I., Miyazaki, Y., Araki, K., Araki, M., Lucas, R., Grau, G.E., Milon, G., Belkaid, Y., Monixi, C., Lesslauer, W., Vassalli, P. (1995) Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25, 2401-2407.
33. Plata-Salaman, C.R., Oomura, Y., Kai, Y. (1988) Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system. Brain Res. 448, 106-114.
34. Hellerstein, M.K., Meydani, S.N., Meydani, M., Dinarello, C.A. (1989) Interleukin-1-induced anorexia in rat. J. Clin. Invest. 84, 228-235.
35. Besedovsky, H.A., del Rey, A., Sorkin, E., Dinarello, C.A. (1986) Immunoregulatory feedback between interleukin-1 and glucocorticoids hormones. Science 233, 652-654.
36. Perlstein, R.S., Mougey, E.H., Jackson, W.E., Neta, R. (1991) Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res. 10, 141-146.
37. Fantuzzi, G., Benigni, F., Sironi, M., Conni, M., Carelli, M., Cantoni, L., Shapiro, L., Dinarello, C.A., Sipe, J.D., Ghezzi, P. (1995) Ciliary neurotrophic factor induces serum amyloid A, hypoglycemia and anorexia, and potentiates IL-1-induced corticosterone and IL-6 production in mice. Cytokine 7, 150-156.
38. Benigni, F., Fantuzzi, G., Sacco, S., Sironi, M., Pozzi, P., Dinarello, C.A., Sipe, J.D., Poli, V., Cappelletti, M., Paonessa, G., Pennica, D., Panayotatos, N., Ghezzi, P. (1996) Six different cytokines that share gp130 as a receptor subunit induce serum amyloid A and potentiate the induction of IL-6 and the activation of the hypothalamus-pituitary-adrenal axis by IL-1. Blood 87, 1851-1854.
39. Ebisui, O., Fukata, J., Murakami, N., Kobayashi, H., Segawa, H., Muro, S., Hanaoka, I., Naito, Y., Masui, Y., Ohmoto, Y., Imura, H., Nakao, K. (1994) Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am. J. Physiol. 266, E986-E992.
40. Rivier, C., Chizzonite, R., Vale, W. (1989) In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125, 2800-2805.
41. Del Rey, A., Besedovsky, H. (1987) Interleukin 1 affects glucose homeostasis. Am. J. Physiol. 253, R794-R798.